Arcus Biosciences - Funding, Financials, Valuation, Investors - Cointime

Bitcoin $88,199.68 -0.46%
Ethereum $2,992.05 -0.81%
BNB $853.71 -0.23%
Optimism $0.27 -1.16%
Arbitrum $0.19 -0.98%
Solana $125.44 +0.08%
Polygon $0.22 +2.77%
Cosmos $1.94 +0.13%
Avalanche $12.36 +2.09%

Bitcoin $88,199.68 -0.46%
Ethereum $2,992.05 -0.81%
BNB $853.71 -0.23%
Optimism $0.27 -1.16%
Arbitrum $0.19 -0.98%
Solana $125.44 +0.08%
Polygon $0.22 +2.77%
Cosmos $1.94 +0.13%
Avalanche $12.36 +2.09%

Arcus Biosciences

company

Investors

Number of Lead Investors

Number of Investors

3

18

Arcus Biosciences is funded by 18 investors. Gilead Sciences and GV are the most recent investors.

Investor Name	Lead Investor	Funding Round
Gilead Sciences	Yes	Post-IPO Equity
GV	Yes	Series C
Aisling Capital	-	Series C
Biotechnology Value Fund	-	Series C
Celgene	-	Series C
Decheng Capital	-	Series C
Droia Ventures	-	Series C
EcoR1 Capital	-	Series C
Foresite Capital	-	Series C
Hillhouse Capital Group	-	Series C
Invus	-	Series C
Leerink Partners	-	Series C
Taiho Ventures	-	Series C
The Column Group	-	Series C
Wellington Management	-	Series C
Novartis	-	Series B
RTA Capital	-	Series B
Stanford University	-	Series B